ZAROXOLYN

This brand name is authorized in Canada, Estonia

Active ingredients

The drug ZAROXOLYN contains one active pharmaceutical ingredient (API):

1 Metolazone
UNII TZ7V40X7VX - METOLAZONE

Metolazone is a diuretic antihypertensive drug for the treatment of edema. Metolazone is a quinazoline diuretic, with properties generally similar to the thiazide diuretics. The actions of metolazone result from interference with the renal tubular mechanism of electrolyte reabsorption.

Read about Metolazone

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
ZAROXOLYN Tablet Health Products and Food Branch (CA) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
C03BA08 Metolazone C Cardiovascular system → C03 Diuretics → C03B Low-ceiling diuretics, excl. thiazides → C03BA Sulfonamides, plain
Discover more medicines within C03BA08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: CA Health Products and Food Branch Identifier(s): 00888400
Country: EE Ravimiamet Identifier(s): 1730966

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.